Vin Tangpricha is an Endocrinology/Metabolic physician affiliated with Emory University. OpenAlex indexes 493 publications with 30,069 citations (h-index 77); ClinicalTrials.gov lists 14 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Progesterone in Gender Affirming Hormone Therapy Study
Sponsor: Emory University
- Systems Biological Assessment of Statin Effect on Vaccine Responses
Sponsor: Emory University
- Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
32.4%Insulin Analog22.4%Lantus Solostar38%Novolog Flexpen34%Novolog29%Part D<11 patientsSGLT2 inhibitor10%Jardiance100%Part D<11 patientsGenitourinary & hormones
26.4%Estrogen18.4%Estradiol63%Estradiol (Once Weekly)37%Part D<11 patientsAndrogen8%Testosterone Cypionate100%Part D<11 patientsHormonal (systemic)
25.2%l-Thyroxine20.4%Synthroid51%Levothyroxine Sodium49%Part D<11 patientsParathyroid Hormone Analog4.8%Forteo100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2011$128,250K23AR054334 - Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2010$128,250K23AR054334 - Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2009$128,250K23AR054334
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD
Emory University
Craig Coopersmith, MD
Emory University
James Lah, MD
Emory University
Vasilis Babaliaros, MD
Emory University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”